GlassScriptPhysician profile
Neel Amin
NPI 1801919410
$17,305.71
in general payments reported to CMS, 2019-2025
45 companies · $3,726 in 2025
The $3,726 reported for 2025 was more than what 88% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,735 · 2020: $2,510 · 2021: $1,917 · 2022: $1,880 · 2023: $2,118 · 2024: $2,420 · 2025: $3,726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,243 · Travel and Lodging: $15.55 · Education: $5.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,243.30 |
| Travel and Lodging | $15.55 |
| Education | $5.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,263.02 | 2019-2025 | Eterna, Proclaim |
| Boston Scientific Corporation | $2,059.74 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Intracept |
| Collegium Pharmaceutical, INC. | $1,774.62 | 2019-2025 | Xtampza |
| Medtronic, INC. | $1,391.63 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Nevro Corp. | $1,164.97 | 2019-2024 | Senza |
| Nalu Medical, INC. | $824.22 | 2021-2025 | Nalu Neurostimulation System |
| Biotronik Nro, INC. | $788.88 | 2025 | Prospera |
| Zyla Life Sciences, INC. | $697.05 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $599.29 | 2019-2023 | Ztlido |
| Allergan, INC. | $584.36 | 2019-2022 | |
| Abbvie INC. | $563.31 | 2021-2025 | Botox, Qulipta, Ubrelvy |
| Horizon Therapeutics Plc | $511.79 | 2019-2022 | |
| Globus Medical, INC. | $451.14 | 2025 | Senza |
| Medtronic USA, INC. | $337.61 | 2019-2020 | |
| Spr Therapeutics, INC | $248.20 | 2024-2025 | Sprint Pns System |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neel Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.